NEPHROS INC (NEPH)

US6406714005 - Common Stock

2.19  -0.08 (-3.52%)

After market: 2.2483 +0.06 (+2.66%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

NEPHROS INC

NASDAQ:NEPH (3/28/2024, 8:26:49 PM)

After market: 2.2483 +0.06 (+2.66%)

2.19

-0.08 (-3.52%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorConsumer Discretionary
GICS IndustryHousehold Durables
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap23.08M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

NEPH Daily chart

Company Profile

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 27 full-time employees. The company went IPO on 2004-09-21. The firm operates through two segments: Water Filtration and Renal Products. The Water Filtration segment primarily develops and sells high-performance water purification filters. The Renal Products segment is focused on the development of medical device products for patients with renal disease, including a second-generation hemodiafiltration system for the treatment of patients with end-stage renal disease (ESRD). The company develops and sells water filtration products used in both medical and commercial applications. The Company’s ultrafiltration products target the markets, including hospitals and other healthcare facilities, dialysis centers and home/portable dialysis machines, commercial facilities, and military and outdoor recreation. The Company’s subsidiaries include Biocon 1, LLC, Aether Water Systems, LLC and Specialty Renal Products, Inc.

Company Info

NEPHROS INC

380 Lackawanna Pl

South Orange NEW JERSEY 07079

P: 12013435202

CEO: Andrew Astor

Employees: 27

Website: https://www.nephros.com/

NEPH News

News Image21 days ago - InvestorPlaceNEPH Stock Earnings: Nephros Misses EPS, Misses Revenue for Q4 2023

NEPH stock results show that Nephros missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

News Image22 days ago - Nephros, Inc. Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million SOUTH ORANGE, NJ, March 07, 2024 (GLOBE NEWSWIRE) -- via...

News Image22 days ago - NewMediaWireNephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

News Imagea month ago - Nephros, Inc. Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

SOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing...

News Imagea month ago - TheNewswire.comNephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

SOUTH ORANGE, NJ - (NewMediaWire) - February 29, 2024 -  Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial results on Thursday March 7, 2024 after market close and will host a conference call that same day at 4:30pm ET.

News Imagea month ago - NewMediaWireNephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

NEPH Twits

Here you can normally see the latest stock twits on NEPH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example